Font: Financial Modeling Prep • Jun 15, 2026
Jabil (NYSE: JBL) is a global electronics manufacturing services (EMS) firm that provides design, production, and product management services. The company operates in high-growth sectors, including artificial intelligence (AI) infrastructure and healthcare technology. It has recently expanded its AI-related partnerships, focusing on advanced technologies like optical transceivers and photonics deployments, showcasing its commitment to innovation and market leadership.
On June 17, 2026, Jabil is set to release its quarterly earnings report. Wall Street analysts estimate an earnings per share (EPS) of $3.09. EPS is a company's profit divided by its number of outstanding shares, showing how profitable it is on a per-share basis, a key indicator for investor analysis.
The company's revenue is expected to be around $8.61 billion. As highlighted by Benzinga, this would be an increase from the $7.83 billion reported in the same period last year. This robust financial growth is supported by strong momentum from its AI and healthcare business segments. Jabil has a history of exceeding earnings estimates, doing so in the last four quarters, demonstrating consistent financial performance.
Jabil's valuation can be seen through its price-to-earnings (P/E) ratio of 50.76. This key investment metric suggests investors are willing to pay $50.76 for every dollar of the company's annual earnings. Another crucial financial metric is its debt-to-equity ratio of 3.27, which compares a company's total debt to its shareholder equity, providing insight into its financial leverage.
|
ADTX§>
Aditxt, Inc.
|
$0.01
0.00%
|
|
GDC§>
GD Culture Group Limited
|
$0.02
-76.40%
|
|
SOXS§>
Direxion Daily Semiconductor Bear 3X ETF
|
$4.53
14.68%
|
|
OBAI§>
Our Bond, Inc.
|
$1.06
98.26%
|
|
IVDA§>
Iveda Solutions, Inc.
|
$0.47
48.36%
|
|
TZA§>
Direxion Daily Small Cap Bear 3X ETF
|
$4.16
2.46%
|
|
GPUS§>
Hyperscale Data, Inc.
|
$0.31
13.75%
|
|
SPCX§>
Space Exploration Technologies Corp.
|
$202.06
4.97%
|
|
SUGP§>
SU Group Holdings Limited Ordinary Shares
|
$1.08
22.65%
|
|
CRVO§>
CervoMed Inc.
|
$4.74
91.13%
|